|
1 |
A phase IIb single‐center study to assess the efficacy of apremilast for the treatment of nummular eczema
Böhner, Alexander. - Freiburg : Universität, 2025
|
|
|
|
2 |
Analysis of predefined safety events across spesolimab trials in dermatological and non-dermatological conditions
Gordon, Kenneth B.. - Freiburg : Universität, 2025
|
|
|
|
3 |
Ayahuasca-inspired DMT/HAR formulation reduces brain differentiation between self and other faces
Suay, Dila. - Freiburg : Universität, 2025
|
|
|
|
4 |
Comparative efficacy of leniolisib (CDZ173) versus standard of care on rates of respiratory tract infection and serum immunoglobulin M (IgM) levels among individuals with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): an externally controlled study
Whalen, John. - Freiburg : Universität, 2025
|
|
|
|
5 |
Coronary plaque, inflammation, subclinical myocardial injury, and major adverse cardiovascular events in the REPRIEVE Substudy
Lu, Michael T.. - Freiburg : Universität, 2025
|
|
|
|
6 |
Intermittent theta burst stimulation of the left dorsolateral prefrontal cortex has no additional effect on the efficacy of virtual reality exposure therapy for acrophobia. A randomized double-blind placebo-controlled study
Bohmeier, Barbara. - Würzburg : Universität Würzburg, 2025
|
|
|
|
7 |
Minimal couple intervention to improve psychobiological stress resilience
Aguilar-Raab, Corina. - Freiburg : Universität, 2025
|
|
|
|
8 |
Octreotide subcutaneous depot for acromegaly: a randomized, double-blind, placebo-controlled phase 3 trial, ACROINNOVA 1
Ferone, Diego. - Freiburg : Universität, 2025
|
|
|
|
9 |
Oral peptide therapeutics as an emerging treatment modality in immune-mediated inflammatory diseases: a narrative review
Stein Gold, Linda F.. - Freiburg : Universität, 2025
|
|
|
|
10 |
Over the counter CBD products in Germany: an exploratory survey about consumption patterns and health related effects
Weissgerber, Anaelle. - Freiburg : Universität, 2025
|
|
Administration
